United Therapeutics: Q2 Earnings Snapshot

United Therapeutics Corp. reported second-quarter net income of $333 million with $7.27 per share, exceeding Wall Street's $6.82 per share estimate. However, revenue of $783.3 million fell short of the $803.5 million forecast.